INS and type 1 diabetes mellitus: In this multinational cohort study of youths with type 1 diabetes, participants who were using real-time CGM with an insulin pump had a significantly higher time in range, were more likely to achieve recommended clinical targets, and had a lower proportion of severe adverse events compared with those using other treatment modalities.